BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28062797)

  • 1. Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
    Uzozie AC; Selevsek N; Wahlander A; Nanni P; Grossmann J; Weber A; Buffoli F; Marra G
    Mol Cell Proteomics; 2017 Mar; 16(3):407-427. PubMed ID: 28062797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.
    Uzozie A; Nanni P; Staiano T; Grossmann J; Barkow-Oesterreicher S; Shay JW; Tiwari A; Buffoli F; Laczko E; Marra G
    Mol Cell Proteomics; 2014 May; 13(5):1198-218. PubMed ID: 24567419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
    You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
    J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
    J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
    Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach.
    Fan NJ; Gao CF; Wang CS; Lv JJ; Zhao G; Sheng XH; Wang XL; Li DH; Liu QY; Yin J
    Can J Gastroenterol; 2012 Jan; 26(1):41-7. PubMed ID: 22288069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
    Tomonaga T; Kume H
    Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
    Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.
    Knol JC; de Wit M; Albrethsen J; Piersma SR; Pham TV; Mongera S; Carvalho B; Fijneman RJ; Meijer GA; Jiménez CR
    Biochim Biophys Acta; 2014 May; 1844(5):1034-43. PubMed ID: 24361553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Biomarker and Therapeutic Target Candidates for Diagnosis and Treatment of Follicular Adenoma.
    Lai X; Chen S
    Cancer Genomics Proteomics; 2015; 12(6):271-81. PubMed ID: 26543076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
    Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
    J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
    Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
    Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome analysis of formalin-fixed paraffin-embedded colorectal adenomas reveals the heterogeneous nature of traditional serrated adenomas compared to other colorectal adenomas.
    Sohier P; Sanson R; Leduc M; Audebourg A; Broussard C; Salnot V; Just PA; Pasmant E; Mayeux P; Guillonneau F; Romagnolo B; Perret C; Terris B
    J Pathol; 2020 Mar; 250(3):251-261. PubMed ID: 31729028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential expression of secretagogin and glucose-related protein 78 in colorectal carcinoma: a proteome study].
    Xing XM; Wang YH; Huang Q; Lü BJ; Lai MD
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):107-12. PubMed ID: 17493385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
    Ludvigsen M; Thorlacius-Ussing L; Vorum H; Stender MT; Thorlacius-Ussing O; Honoré B
    Curr Issues Mol Biol; 2021 Sep; 43(2):1043-1056. PubMed ID: 34563043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
    Kahlert C; Lerbs T; Pecqueux M; Herpel E; Hoffmeister M; Jansen L; Brenner H; Chang-Claude J; Bläker H; Kloor M; Roth W; Pilarsky C; Rahbari NN; Schölch S; Bork U; Reissfelder C; Weitz J; Aust D; Koch M
    Int J Cancer; 2015 Nov; 137(9):2104-13. PubMed ID: 25951369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.
    O'Dwyer D; Ralton LD; O'Shea A; Murray GI
    PLoS One; 2011; 6(11):e27718. PubMed ID: 22125622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.
    Takadate T; Onogawa T; Fukuda T; Motoi F; Suzuki T; Fujii K; Kihara M; Mikami S; Bando Y; Maeda S; Ishida K; Minowa T; Hanagata N; Ohtsuka H; Katayose Y; Egawa S; Nishimura T; Unno M
    Int J Cancer; 2013 Mar; 132(6):1368-82. PubMed ID: 22915188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study.
    Wang Y; Ma Y; Lü B; Xu E; Huang Q; Lai M
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1152-9. PubMed ID: 17895523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.